2m 2m 2m 2m 2m 2m 2m
CytomX Therapeut (CTMX)
NASDAQ
$2.44+$0.04 (+1.67%)
Price as of Oct 22, 2026 6:16 PM EDT- $523.0MMarket Cap
- -29.20%1-Year Change
- BiotechnologyIndustry
CytomX Therapeut (CTMX)
$2.44+$0.04 (+1.67%)
CTMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.40 | ||
Change | -$0.11 (-4.38%) | ||
Open | $2.52 | ||
High | $2.61 | ||
Low | $2.39 | ||
Previous Close | $2.51 | ||
Volume | 3,111,059 | ||
30-Day Average Volume | 3,421,178 | ||
1-Week Change | 7.62% | ||
1-Month Change | -13.04% | ||
1-Year Change | -29.20% | ||
3-Year Change | 80.45% | ||
5-Year Change | -53.03% | ||
Fundamentals | |||
Shares Outstanding | 217.9M | ||
Total Assets | $381.2M | ||
Market Cap | $523.0M | ||
Enterprise Value | $505.7M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$20.7M | ||
Free Cash Flow | -$18.1M | ||
EBIT | -$20.6M | ||
EBITDA | -$20.6M | ||
Net Working Capital | $333.3M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 357 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue